Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs041180131Phase 2Completed
Phase 2, open-label, single-arm trial in lymphoblastic lymphoma (LL), sponsored by Ministry of Health, Labour and Welfare. Primary endpoint: 3-year event-free survival. Started Mar 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs041180131.